|
1
|
Pona A, Cline A, Kolli SS, Taylor SL and
Feldman SR: Review of future insights of Dragon's Blood in
dermatology. Dermatol Ther. 32(e12786)2019.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Sousa MM, Melo MJ, Parola AJ, Seixas de
Melo JS, Catarino F, Pina F, Cook FE, Simmonds MS and Lopes JA:
Flavylium chromophores as species markers for dragon's blood resins
from Dracaena and Daemonorops trees. J Chromatogr A.
1209:153–161. 2008.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Edwards HG, de Oliveira LF and Prendergast
HD: Raman spectroscopic analysis of dragon's blood resins-basis for
distinguishing between Dracaena (Convallariaceae),
Daemonorops (Palmae) and Croton (Euphorbiaceae).
Analyst. 129:134–138. 2004.PubMed/NCBI View
Article : Google Scholar
|
|
4
|
Wu C, Cai XQ, Chang Y, Chen CH, Ho TJ, Lai
SC and Chen HP: Rapid identification of dragon blood samples from
Daemonorops draco, Dracaena cinnabari and Dracaena
cochinchinensis by MALDI-TOF mass spectrometry. Phytochem Anal.
30:720–726. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
5
|
Al-Okaishi A: Exploring the historical
distribution of Dracaena cinnabari using ethnobotanical
knowledge on Socotra Island, Yemen. J Ethnobiol Ethnomed.
17(22)2021.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Wu KC: Quality evaluation of herbal
medicine Ercha, Xuejie, Ruxiang and Moyao. Master Thesis, China
Medical University, 2011.
|
|
7
|
Department of Health, Hong Kong Special
Administrative Region: Hong Kong Chinese Materia Medica strandards.
The People's Republic of China: Department of Health, Hong Kong
Special Administrative Region, 362-368, 2005.
|
|
8
|
State Pharmacopoeia Commission of the PRC:
Pharmacopoeia of the People's Republic of China. 1 Beijing,
People's Medical Publishing House, p142, 2015.
|
|
9
|
Taiwan Herbal Pharmacopeia Editorial Panel
Committee. Taiwan Herbal Pharmacopeia, version 2. Taipei: Ministry
of Health and Welfare, Executive Yuan, pp102-103, 2013.
|
|
10
|
Krishnaraj P, Chang Y, Ho TJ, Lu NC, Lin
MD and Chen HP: In vivo pro-angiogenic effects of dracorhodin
perchlorate in zebrafish embryos: A novel bioactivity evaluation
platform for commercial dragon blood samples. J Food Drug Anal.
27:259–265. 2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Namjoyan F, Kiashi F, Moosavi ZB, Saffari
F and Makhmalzadeh BS: Efficacy of Dragon's blood cream on wound
healing: A randomized, double-blind, placebo-controlled clinical
trial. J Tradit Complement Med. 6:37–40. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Li D, Hui R, Hu Y, Han Y and Guo S:
Effects of extracts of Dragon's blood on fibroblast proliferation
and extracellular matrix hyaluronic acid. Zhonghua Zheng Xing Wai
Ke Za Zhi. 31:53–57. 2015.PubMed/NCBI(In Chinese).
|
|
13
|
Xin N, Yang FJ, Li Y, Li YJ, Dai RJ, Meng
WW, Chen Y and Deng YL: Dragon's blood dropping pills have
protective effects on focal cerebral ischemia Rats model.
Phytomedicine. 21:68–74. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Ho TJ, Jiang SJ, Lin GH, Li TS, Yiin LM,
Yang JS, Hsieh MC, Wu CC, Lin JG and Chen HP: The in vitro and in
vivo Wound Healing Properties of the Chinese Herbal medicine
‘Jinchuang Ointment’. Evid Based Complement Alternat Med.
2016(1654056)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Xia M, Wang D, Wang M, Tashiro S, Onodera
S, Minami M and Ikejima T: Dracorhodin perchlorate induces
apoptosis via activation of caspases and generation of reactive
oxygen species. J Pharmacol Sci. 95:273–283. 2004.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Xia MY, Wang MW, Cui Z, Tashiro SI,
Onodera S, Minami M and Ikejima T: Dracorhodin perchlorate induces
apoptosis in HL-60 cells. J Asian Nat Prod Res. 8:335–343.
2006.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Wang Y, Wang Q, Liu J, Zhang L and Zhang
B: Dracorhodin perchlorate inhibit high glucose-induced connective
tissue growth factor formation in human mesangial cells. Zhongguo
Zhong Yao Za Zhi. 34:896–899. 2009.PubMed/NCBI(In Chinese).
|
|
18
|
He Y, Ju W, Hao H, Liu Q, Lv L and Zeng F:
Dracorhodin perchlorate suppresses proliferation and induces
apoptosis in human prostate cancer cell line PC-3. J Huazhong Univ
Sci Technolog Med Sci. 31(215)2011.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Li F, Jiang T, Liu W, Hu Q and Yin H: The
angiogenic effect of dracorhodin perchlorate on human umbilical
vein endothelial cells and its potential mechanism of action. Mol
Med Rep. 14:1667–1672. 2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Chen X, Luo J, Meng L, Pan T, Zhao B, Tang
ZG and Dai Y: Dracorhodin perchlorate induces the apoptosis of
glioma cells. Oncol Rep. 35:2364–2372. 2016.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Zhang G, Sun M, Zhang Y, Hua P, Li X, Cui
R and Zhang X: Dracorhodin perchlorate induces G1/G0 phase arrest
and mitochondria-mediated apoptosis in SK-MES-1 human lung squamous
carcinoma cells. Oncol Lett. 10:240–246. 2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Yu JH, Zheng GB, Liu CY, Zhang LY, Gao HM,
Zhang YH, Dai CY, Huang L, Meng XY, Zhang WY and Yu XF: Dracorhodin
perchlorate induced human breast cancer MCF-7 apoptosis through
mitochondrial pathways. Int J Med Sci. 10:1149–1156.
2013.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Rasul A, Ding C, Li X, Khan M, Yi F, Ali M
and Ma T: Dracorhodin perchlorate inhibits PI3K/Akt and NF-κB
activation, up-regulates the expression of p53, and enhances
apoptosis. Apoptosis. 17:1104–1119. 2012.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xia M, Wang M, Tashiro S, Onodera S,
Minami M and Ikejima T: Dracorhodin perchlorate induces A375-S2
cell apoptosis via accumulation of p53 and activation of caspases.
Biol Pharm Bull. 28:226–232. 2005.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Xia MY, Wang MW, Wang HR, Tashiro S and
Ikejima T: Mechanism of dracorhodin perchlorate-induced Hela cell
apoptosis. Yao Xue Xue Bao. 39:966–970. 2004.PubMed/NCBI(In Chinese).
|
|
26
|
Jiang X, Liu L, Qiao L, Zhang B, Wang X,
Han Y and Yu W: Dracorhodin perchlorate regulates fibroblast
proliferation to promote rat's wound healing. J Pharmacol Sci.
136:66–72. 2018.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Jiang XW, Qiao L, Liu L, Zhang BQ, Wang
XW, Han YW and Yu WH: Dracorhodin Perchlorate Accelerates Cutaneous
Wound Healing in Wistar Rats. Evid Based Complement Alternat Med.
2017(8950516)2017.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Boukamp P, Petrussevska RT, Breitkreutz D,
Hornung J, Markham A and Fusenig NE: Normal keratinization in a
spontaneously immortalized aneuploid human keratinocyte cell line.
J Cell Biol. 106:761–771. 1988.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Xia Q, Chiang HM, Yin JJ, Chen S, Cai L,
Yu H and Fu PP: UVA photoirradiation of benzo[a]pyrene metabolites:
Induction of cytotoxicity, reactive oxygen species, and lipid
peroxidation. Toxicol Ind Health. 31:898–910. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Gelles JD and Chipuk JE: Robust
high-throughput kinetic analysis of apoptosis with real-time
high-content live-cell imaging. Cell Death Dis.
7(e2493)2016.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Lee MR, Lin C, Lu CC, Kuo SC, Tsao JW,
Juan YN, Chiu HY, Lee FY, Yang JS and Tsai FJ: YC-1 induces G0/G1
phase arrest and mitochondria-dependent apoptosis in
cisplatin-resistant human oral cancer CAR cells. Biomedicine
(Taipei). 7(12)2017.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Yuan CH, Horng CT, Lee CF, Chiang NN, Tsai
FJ, Lu CC, Chiang JH, Hsu YM, Yang JS and Chen FA: Epigallocatechin
gallate sensitizes cisplatin-resistant oral cancer CAR cell
apoptosis and autophagy through stimulating AKT/STAT3 pathway and
suppressing multidrug resistance 1 signaling. Environ Toxicol.
32:845–855. 2017.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chang HP, Lu CC, Chiang JH, Tsai FJ, Juan
YN, Tsao JW, Chiu HY and Yang JS: Pterostilbene modulates the
suppression of multidrug resistance protein 1 and triggers
autophagic and apoptotic mechanisms in cisplatin-resistant human
oral cancer CAR cells via AKT signaling. Int J Oncol. 52:1504–1514.
2018.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lee HP, Chen PC, Wang SW, Fong YC, Tsai
CH, Tsai FJ, Chung JG, Huang CY, Yang JS, Hsu YM, et al: Plumbagin
suppresses endothelial progenitor cell-related angiogenesis in
vitro and in vivo. J Funct Foods. 52:537–544. 2019.
|
|
35
|
Chiang JH, Yang JS, Lu CC, Hour MJ, Chang
SJ, Lee TH and Chung JG: Newly synthesized quinazolinone HMJ-38
suppresses angiogenetic responses and triggers human umbilical vein
endothelial cell apoptosis through p53-modulated Fas/death receptor
signaling. Toxicol Appl Pharmacol. 269:150–162. 2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Ma YS, Weng SW, Lin MW, Lu CC, Chiang JH,
Yang JS, Lai KC, Lin JP, Tang NY, Lin JG and Chung JG: Antitumor
effects of emodin on LS1034 human colon cancer cells in vitro and
in vivo: Roles of apoptotic cell death and LS1034 tumor xenografts
model. Food Chem Toxicol. 50:1271–1278. 2012.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tsai YF, Chen YF, Hsiao CY, Huang CW, Lu
CC, Tsai SC and Yang JS: Caspase dependent apoptotic death by
gadolinium chloride (GdCl3) via reactive oxygen species production
and MAPK signaling in rat C6 glioma cells. Oncol Rep. 41:1324–1332.
2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Chiu YJ, Hour MJ, Jin YA, Lu CC, Tsai FJ,
Chen TL, Ma H, Juan YN and Yang JS: Disruption of IGF-1R signaling
by a novel quinazoline derivative, HMJ-30, inhibits invasiveness
and reverses epithelial-mesenchymal transition in osteosarcoma U-2
OS cells. Int J Oncol. 52:1465–1478. 2018.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Lu CC, Chiang JH, Tsai FJ, Hsu YM, Juan
YN, Yang JS and Chiu HY: Metformin triggers the intrinsic apoptotic
response in human AGS gastric adenocarcinoma cells by activating
AMPK and suppressing mTOR/AKT signaling. Int J Oncol. 54:1271–1281.
2019.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Han J, Lee JD, Bibbs L and Ulevitch RJ: A
MAP kinase targeted by endotoxin and hyperosmolarity in mammalian
cells. Science. 265:808–811. 1994.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Zhang P, Li J, Tang X, Zhang J, Liang J
and Zeng G: Dracorhodin perchlorate induces apoptosis in primary
fibroblasts from human skin hypertrophic scars via participation of
caspase-3. Eur J Pharmacol. 728:82–92. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Bowley E, O'Gorman DB and Gan BS:
Beta-catenin signaling in fibroproliferative disease. J Surg Res.
138:141–150. 2007.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Lindley LE, Stojadinovic O, Pastar I and
Tomic-Canic M: Biology and biomarkers for wound healing. Plast
Reconstr Surg. 138 (Suppl 3):S18–S28. 2016.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Pereira Beserra F, Xue M, Maia GLA, Leite
Rozza A, Helena Pellizzon C and Jackson CJ: Lupeol, a Pentacyclic
Triterpene, promotes migration, wound closure, and contractile
effect in vitro: Possible involvement of PI3K/Akt and p38/ERK/MAPK
Pathways. Molecules. 23(2819)2018.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Patruno A, Pesce M, Grilli A, Speranza L,
Franceschelli S, De Lutiis MA, Vianale G, Costantini E, Amerio P,
Muraro R, et al: mTOR activation by PI3K/Akt and ERK signaling in
short ELF-EMF exposed human keratinocytes. PLoS One.
10(e0139644)2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Bui NT, Ho MT, Kim YM, Lim Y and Cho M:
Flavonoids promoting HaCaT migration: II. Molecular mechanism of
4',6,7-trimethoxyisoflavone via NOX2 activation. Phytomedicine.
21:570–577. 2014.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Yang HL, Tsai YC, Korivi M, Chang CT and
Hseu YC: Lucidone promotes the Cutaneous Wound Healing process via
activation of the PI3K/AKT, Wnt/β-catenin and NF-κB
signaling pathways. Biochim Biophys Acta Mol Cell Res.
1864:151–168. 2017.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Lee SH, Zahoor M, Hwang JK, Min do S and
Choi KY: Valproic acid induces cutaneous wound healing in vivo and
enhances keratinocyte motility. PLoS One. 7(e48791)2012.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Yeh CJ, Chen CC, Leu YL, Lin MW, Chiu MM
and Wang SH: The effects of artocarpin on wound healing: In vitro
and in vivo studies. Sci Rep. 7(15599)2017.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Chen J, Chen Y, Chen Y, Yang Z, You B,
Ruan YC and Peng Y: Epidermal CFTR Suppresses MAPK/NF-κB to Promote
Cutaneous Wound Healing. Cell Physiol Biochem. 39:2262–2274.
2016.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Gazel A, Nijhawan RI, Walsh R and
Blumenberg M: Transcriptional profiling defines the roles of ERK
and p38 kinases in epidermal keratinocytes. J Cell Physiol.
215:292–308. 2008.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Saika S, Okada Y, Miyamoto T, Yamanaka O,
Ohnishi Y, Ooshima A, Liu CY, Weng D and Kao WW: Role of p38 MAP
kinase in regulation of cell migration and proliferation in healing
corneal epithelium. Invest Ophthalmol Vis Sci. 45:100–109.
2004.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Sharma GD, He J and Bazan HE: p38 and
ERK1/2 coordinate cellular migration and proliferation in
epithelial wound healing: Evidence of cross-talk activation between
MAP kinase cascades. J Biol Chem. 278:21989–21997. 2003.PubMed/NCBI View Article : Google Scholar
|
